Deverra Therapeutics has filed a notice of an exempt offering of securities to raise $2,388,889.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Deverra Therapeutics is raising $2,388,889.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Yurkowsky played a key role…